Generic and specialty pharmaceuticals company Mylan acquired Abbott Laboratories’ non-U.S. developed markets specialty and branded generics business. During the transaction COBALT acted as legal advisor for Abbott Laboratories on Latvian corporate law, pharmaceuticals law and data protection issues.
COBALT advises Abbott Laboratories on sale to Mylan of non-U.S. developed markets specialty and branded generics business
2015 - 02 - 11
